Walter V. Klemp
Net Worth

Last updated:

What is Walter V. Klemp net worth?

The estimated net worth of Mr. Walter V. Klemp is at least $7,130,957 as of 16 Jun 2024. He owns shares worth $401,787 as insider, has earned $170,300 from insider trading and has received compensation worth at least $6,558,870 in Moleculin Biotech, Inc. and Soliton, Inc..

What is the salary of Walter V. Klemp?

Mr. Walter V. Klemp salary is $778,140 per year as Founder, Chairman, Pres & Chief Executive Officer in Moleculin Biotech, Inc.. He also receives $333,750 as Co-Founder & Executive Chairman in Soliton, Inc..

How old is Walter V. Klemp?

Mr. Walter V. Klemp is 65 years old, born in 1960.

What stocks does Walter V. Klemp currently own?

As insider, Mr. Walter V. Klemp owns shares in one company:

Company Title Shares Price per share Total value
Moleculin Biotech, Inc. (MBRX) Founder, Chairman, Pres & Chief Executive Officer 680,880 $0.59 $401,787

What does Moleculin Biotech, Inc. do?

Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company has partnership and collaboration agreements with MD Anderson; Animal Life Sciences, LLC; and WPD Pharmaceuticals Sp z.o.o. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas.

MBRX logo
MBRX
Moleculin Biotech, Inc.
$0.59

Walter V. Klemp insider trading

Moleculin Biotech, Inc.

Mr. Walter V. Klemp has made only one insider trade between 2017-2024, according to the Form 4 filled with the SEC.

As of 16 Jun 2024 he still owns at least 680,880 units of MBRX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 1,667 N/A N/A
Option
Common Stock 1,667 N/A N/A
Purchase
Common Stock 188,404 $0.69 $129,999
Option
Common Stock 13,204 N/A N/A
Option
Restricted Stock Units 13,204 N/A N/A
Option
Common Stock 14,717 N/A N/A
Option
Restricted Stock Units 14,717 N/A N/A
Option
Restricted Stock Units 56,250 N/A N/A
Option
Common Stock 56,250 N/A N/A
Option
Common Stock 25,000 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Purchase
Common Stock 45,000 $1.28 $57,645
Purchase
Common Stock 22,500 $1.15 $25,875
Purchase
Common Stock 24,742 $1.02 $25,262
Purchase
Common Stock 85,213 $0.97 $82,657
Option
Common Stock 13,204 N/A N/A
Option
Restricted Stock Units 13,205 N/A N/A
Option
Restricted Stock Units 13,205 N/A N/A
Option
Common Stock 14,717 N/A N/A
Option
Restricted Stock Units 14,717 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Option
Common Stock 13,205 N/A N/A
Option
Restricted Stock Units 13,205 N/A N/A
Option
Common Stock 14,718 N/A N/A
Option
Restricted Stock Units 14,718 N/A N/A
Option
Common Stock 79,227 N/A N/A
Option
Restricted Stock Units 79,227 N/A N/A
Sale
Common Stock 100,000 $1.7 $170,300
Purchase
Common Stock 12,000 $0.81 $9,720

Moleculin Biotech key executives

Moleculin Biotech, Inc. executives and other stock owners filed with the SEC: